Max Perryman

What Is Orforglipron? Investigational, once-daily  oral  GLP-1 receptor agonist. Non-peptide, small-molecule compound (unlike many existing GLP-1 drugs, which are peptides/injectables). Designed to treat: Type 2 diabetes (T2D) Obesity / weight management  in adults (with or without diabetes) According to sources, can be taken without food or water restrictions, making administration more flexible. Not yet FDA approved (as of now). Clinical Data & Efficacy Here are the standout...

Semaglutide, Tirzepatide and Retatrutide are three different types of GLP-1 agonists. Learn the effects of each and how to properly dose them.

Harnessing the Power of GLP-1s + Peptides for Maximum Results Your health goals are unique — and so should be your approach. GLP-1 medications like Semaglutide  and Tirzepatide  are transforming weight management worldwide. Now, by pairing them with advanced regenerative peptides, you can amplify results, support recovery, and boost overall vitality. In this month’s spotlight, we’re exploring three powerful combinations: 1. Semaglutide or Tirzepatide + CJC-1295 / Ipamorelin For: Weight Loss,...